12,131 followers
RT @FrontOncology: New research: Patient-reported experiences during and following treatment with belantamab mafodotin for relapsed/refract…
RT @FrontOncology: New research: Patient-reported experiences during and following treatment with belantamab mafodotin for relapsed/refract…
New research: Patient-reported experiences during and following treatment with belantamab mafodotin for relapsed/refractory multiple myeloma in the DREAMM-2 study: Introduction Patients with relapsed or refractory multiple myeloma (RRMM) are… https://t.co